Inhibitors of cerebroside metabolism.
D000818:Animals; D002554:Cerebrosides / Q000378:metabolism*; D005698:Galactosylceramidase / Q000037:antagonists & inhibitors; D005962:Glucosylceramidase / Q000037:antagonists & inhibitors; D005964:Glucosyltransferases / Q000037:antagonists & inhibitors; D007202:Indicators and Reagents; D007294:Inositol / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D009025:Morpholines / Q000138:chemical synthesis* / Q000494:pharmacology; D011427:Propiophenones / Q000138:chemical synthesis* / Q000494:pharmacology; D011409:Propylene Glycols / Q000138:chemical synthesis* / Q000494:pharmacology; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology
D002554:Cerebrosides; D007202:Indicators and Reagents; D009025:Morpholines; D011427:Propiophenones; D011409:Propylene Glycols; C033111:2-(2'-hydroxydodecanoyl)amino-1-phenyl-1,3-propanediol; C033108:N-hexylglucosylsphingosine; D007294:Inositol; C033110:RV 538; C033109:2-decanoylamino-3-morpholinopropiophenone; D005964:Glucosyltransferases; C023246:ceramide glucosyltransferase; D005962:Glucosylceramidase; D005698:Galactosylceramidase; D013110:Sphingosine; C011423:conduritol epoxide